Biosynthesis, characterization and inhibition of leukotriene B4 in human whole blood.
We have evaluated the biosynthesis, characterization and inhibition of Leukotriene (LT) B4 in unstimulated and in A23187-stimulated human whole blood. LTB4 was assayed by radioimmunoassay (RIA) both in unextracted serum and after extraction and thin-layer chromatography (TLC). Unstimulated human whole blood allowed to clot at 37 degrees C for 60 min produced only trace amounts of LTB4 (0.16 +/- 0.05 ng/ml, mean +/- SD, n = 3). LTB4-like immunoreactivity (ir-LTB4) detectable in unstimulated serum samples was largely overestimated by direct RIA, most likely because of interfering substance(s) unrelated to cyclooxygenase or lipoxygenase activity. Incubation of human whole blood with A23187 (2-10 microM) resulted in a concentration-dependent stimulation of LTB4 production. At 10 microM A23187, ir-LTB4 was 18 +/- 2.4 ng/ml (mean +/- SEM, n = 28). In A23187-stimulated serum samples, LTB4 concentrations measured by direct RIA correlated in a statistically significant fashion with those measured after extraction and TLC. Nafazatrom added in vitro caused a dose-dependent inhibition of A23187-stimulated ir-LTB4 production with an IC50 of 17 microM.
D001241:Aspirin / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D003429:Cross Reactions; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D007106:Immune Sera; D007700:Kinetics; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000097:blood*; D011720:Pyrazoles / Q000494:pharmacology; D047069:Pyrazolones; D011863:Radioimmunoassay
D005343:Fibrinolytic Agents; D007106:Immune Sera; D011720:Pyrazoles; D047069:Pyrazolones; D007975:Leukotriene B4; D000001:Calcimycin; C018845:nafazatrom; D001241:Aspirin